Post-marketing safety surveillance for the adjuvanted recombinant zoster vaccine: methodology
mediaposted on 2020-08-30, 21:25 authored by Fernanda Tavares Da Silva, Olivia Mahaux, Lionel Van Holle, François Haguinet, Harry Seifert, Jens-Ulrich Stegmann
The above video represents the opinions of
the authors. For a full list of declarations, including
funding and author disclosure statements, please see the full text online (see
“read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC .